Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA bid1870 gCSI pan-cancer AAC -0.16 0.005
mRNA alvocidib CTRPv2 pan-cancer AAC 0.14 0.006
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.084 0.006
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.088 0.006
mRNA istradefylline CTRPv2 pan-cancer AAC 0.16 0.006
mRNA SB52334 GDSC1000 pan-cancer AAC 0.091 0.006
mRNA RAF265 CCLE pan-cancer AAC -0.14 0.006
mRNA FK866 GDSC1000 pan-cancer AAC 0.084 0.007
mRNA B02 CTRPv2 pan-cancer AAC 0.1 0.007
mRNA YM201636 GDSC1000 pan-cancer AAC 0.085 0.007
Download CSV